GRI And SASB Summary

Overview

The report summarizes Royalty Pharma's fiscal 2021 ESG activities and disclosures for January 1 through December 31, 2021. It reports 67 total workers and a workforce composition of 51% male and 49% female. The GHG overview shows Scope 2 market and location emissions of 113 MT CO2e each, plus 851 MT CO2e from Scope 3 Category 6 and 15,679 MT CO2e from Category 15; Scope 1 is shown as "-". The report also says it completed its first materiality assessment in 2022 and that the Board oversees ESG.

Document

Report type: GRI Content Index
Class: Specialized
Scope: Condensed report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 21 December 2022
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services